rhGGF2 protects against cisplatin-induced neuropathy in the rat
- 29 March 2000
- journal article
- research article
- Published by Wiley in Journal of Neuroscience Research
- Vol. 60 (2) , 237-244
- https://doi.org/10.1002/(sici)1097-4547(20000415)60:2<237::aid-jnr13>3.0.co;2-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Effect of Recombinant Human Nerve Growth Factor on Cisplatin Neurotoxicity in RatsExperimental Neurology, 1999
- Neurotrophin‐3 reverses experimental cisplatin‐induced peripheral sensory neuropathyAnnals of Neurology, 1995
- Neurotrophic factor therapy for nervous system degenerative diseasesJournal of Neurobiology, 1994
- Neurotoxic side-effects of cisplatinEuropean Journal of Cancer and Clinical Oncology, 1991
- Cisplatin NeurotoxicityNew England Journal of Medicine, 1990
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721Cancer, 1988
- Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsEuropean Journal of Cancer and Clinical Oncology, 1988
- Org.2766 protects from cisplatin-induced neurotoxicity in ratsExperimental Neurology, 1987
- New factor released by cultured glioma cells supporting survival and growth of sensory neuronesNature, 1978